Mirtazapine Tablet, Film Coated
Product Images NDC 0904-6519

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 0904-6519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A17aa328 E5bb 401d A47c F15872698d18 00

A17aa328 E5bb 401d A47c F15872698d18 00
Mirtazapine 15 mg film-coated tablets carton label from Major Pharmaceuticals. The label shows the product name, strength, dosage form, and quantity of 100 tablets with directions for pharmacists to dispense with a medication guide. It includes storage instructions and manufacturer details for Apotex Inc. and Apotex Corp.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of the active ingredient Mirtazapine, showing its molecular framework with rings and bonds characteristic of its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.